Related Experiment Video

Updated: May 17, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Conditional survival of patients with metastatic renal-cell carcinoma

Maxine Sun, Quoc-Dien Trinh, Pierre I Karakiewicz

    The Lancet. Oncology
    |November 3, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
    11:27

    Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

    Published on: April 29, 2014

    Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
    05:36

    Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

    Published on: February 8, 2020

    Related Experiment Videos

    Last Updated: May 17, 2026

    A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
    06:38

    A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

    Published on: April 12, 2017

    Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
    11:27

    Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

    Published on: April 29, 2014

    Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
    05:36

    Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

    Published on: February 8, 2020

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

    Articles linked to this work by shared authors, journal, and citation graph.

    Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    First and Second-line Treatments in Metastatic Renal Cell Carcinoma.

    European urology·2024

    Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.

    Nature genetics·2024

    Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes.

    Cancer cell·2024

    A Nationwide Survey of Prostate Specific Antigen Based Screening and Counseling for Prostate Cancer.

    Urology practice·2023

    Factors Influencing Prostate Specific Antigen Testing in the United States.

    Urology practice·2023

    Global health expenditures on cancer control: a cross-sectional analysis.

    The Lancet. Oncology·2026

    Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study.

    The Lancet. Oncology·2026

    Burden of cancer in Africa, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023.

    The Lancet. Oncology·2026

    Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial.

    The Lancet. Oncology·2026

    Development and external validation of a new prognostic model for metastatic clear cell renal cell carcinoma: a preregistered analysis using data from randomised clinical trials in the checkpoint inhibitor era.

    The Lancet. Oncology·2026

    Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial.

    The Lancet. Oncology·2026

    Frailty Assessment and Its Impact in Hospital Outcomes After Cardiac Surgery - A Prospective Observational Study.

    Brazilian journal of cardiovascular surgery·2026

    Changes in Susceptibility to Cannabis Use From Late Childhood to Early Adolescence.

    The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2026

    Potentially inappropriate care at the end of life in patients with glioblastoma: A single-center observational cohort study.

    Neuro-oncology·2026

    Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma.

    Neuro-oncology·2026

    Comparing methodological approaches for outlier detection: a cross-sectional study of older persons in 2,744 Australian long-term care facilities.

    International journal for quality in health care : journal of the International Society for Quality in Health Care·2026

    FIN-EGFR: real-world treatment outcomes by EGFR mutational subtypes in NSCLC in Southern Finland.

    Acta oncologica (Stockholm, Sweden)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us